Search results
Found 12689 matches for
Welcome to OXION, Universities of Oxford, Cambridge, London and MRC Harwell
Paul Riley appointed Director of Oxford’s Institute of Developmental and Regenerative Medicine
9 October 2020
Professor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world’s most prolific diseases.
Ana Domingos joins the Cell Metabolism Advisory Board
6 October 2020
Congratulations are in order to Associate Professor Ana Domingos on her appointment to the Advisory Board of the top research journal dedicated to publishing novel, impactful papers spanning basic to clinical metabolic research.
Sonali Munshaw is an IVBM E-poster Award Winner
2 October 2020
Congratulations are in order to Graduate Student Sonali Munshaw, whose abstract submitted to the 21st International Vascular Biology meeting was selected for E-Poster presentation and awarded.
Sites of early dysfunction in Parkinson's identified
2 October 2020
A new collaborative study from the Oxford Parkinson’s Disease Centre led by Prof Stephanie Cragg and Dr Bradley Roberts has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.
Sites of early dysfunction in Parkinson's identified
2 October 2020
A new collaborative study from the Oxford Parkinson’s Disease Centre led by Prof Stephanie Cragg and Dr Bradley Roberts has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.
Tiny brain “tweezers” could hold the key to treat Parkinson’s
28 September 2020
A collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.
Tiny brain “tweezers” could hold the key to treat Parkinson’s
28 September 2020
A collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.
Einstein Visiting Fellowship awarded to Zoltán Molnár
24 September 2020
Professor Zoltán Molnár has been awarded an Einstein Visiting Fellowship to Charité - University Medicine, Berlin. This award sees him join the dynamic Oxford | Berlin collaboration, a strategic research partnership that supports high quality joint research initiatives across all disciplines of its member institutions, of which Neuroscience is a major focus.
Deborah Goberdhan elected to the International Society for Extracellular Vesicles Executive Board
24 September 2020
Congratulations are in order to Associate Professor Deborah Goberdhan on her election to the leading global organisation for advancing the research of extracellular vesicles, which represent an important mode of intercellular communication in diverse cellular processes such as our immune responses.
Dayne Beccano-Kelly appointed World Parkinson Coalition Science Ambassador
22 September 2020
The World Parkinson Coalition has brought in eight new Science Ambassadors to increase outreach to researchers ahead of their next major Congress.
Dayne Beccano-Kelly appointed World Parkinson Coalition Science Ambassador
22 September 2020
The World Parkinson Coalition has brought in eight new Science Ambassadors to increase outreach to researchers ahead of their next major Congress.
Recharging the battery of the diabetic heart
4 September 2020
A new paper from the Heather and Tyler groups has uncovered the mechanism responsible for reduced energy in the hearts of patients with type 2 diabetes and revealed a new therapeutic strategy to reverse the energy deficit.
Acidic niche keeps lymphatic system in check during immune response
1 September 2020
Collaborative research from a leading US cancer centre and the Swietach Group has found that Low pH in lymph nodes inhibits effector T cells, while still allowing T cell activation.
Genetic study points to cells responsible for Parkinson’s
25 August 2020
New results from a collaborative Oxford Parkinson’s Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments.
Genetic study points to cells responsible for Parkinson’s
25 August 2020
New results from a collaborative Oxford Parkinson’s Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments.
Natalie Connor-Robson widens access to STEM skills with In2scienceUK
14 August 2020
OPDC Career Development Fellow Natalie Connor-Robson was first generation in her family to go to university and is now delighted to be sharing STEM career advice with students taking part in the In2scienceUK programme.
Natalie Connor-Robson widens access to STEM skills with In2scienceUK
14 August 2020
OPDC Career Development Fellow Natalie Connor-Robson was first generation in her family to go to university and is now delighted to be sharing STEM career advice with students taking part in the In2scienceUK programme.
How brain networks cooperate to control our sleep
13 August 2020
Two new papers from the Vyazovskiy Group and both Oxford University and international collaborators have made important progress in bridging the gap between the local and global levels of sleep regulation.
Richard Tyser is British Science Association Award Lecturer on finding the first heartbeat
11 August 2020
Congratulations are in order to Dr Richard Tyser, who is the 2020 Charles Darwin Award Lecture winner for Agriculture, Biological and Medical Sciences.
The ethical cost of doing nothing
7 August 2020
In the wake of concern raised about the ethics and risks of performing genetic interventions in macaque monkeys to study models of human neuropsychiatric conditions, Professor Andrew Parker analyses how decision makers evaluate these situations and highlights the ethical consequences if research is not carried out.
